A novel rosiglitazone-phosphatidylserine composite nanoparticle mediated targeted drug delivery to macrophages for treatment of ulcerative colitis
{"AIMS:":[0],"The":[1],"treatment":[2],"of":[3,19,31],"ulcerative":[4,64],"colitis(UC)":[5],"remains":[6],"a":[7,23,71,168],"significant":[8],"challenge":[9],"contributing":[10],"to":[11,105],"the":[12,39,80,111,114,125],"growing":[13],"global":[14],"healthcare":[15],"burden.":[16],"Efficient":[17],"clearance":[18],"apoptotic":[20],"cells":[21],"is":[22,95],"crucial":[24],"mechanism":[25],"for":[26,62],"tissue":[27,45,108,123],"repair":[28],"and":[29,44,51,102,136,149,163],"maintenance":[30],"homeostasis":[32],"following":[33],"inflammatory":[34,42,119],"damage.":[35],"Macrophages":[36],"critically":[37],"govern":[38],"balance":[40],"between":[41],"responses":[43,120],"regeneration.":[46],"Therefore,":[47],"precisely":[48],"targeting":[49],"macrophages":[50,104,139],"activating":[52],"their":[53],"anti-inflammatory":[54,158],"functions":[55],"could":[56],"serve":[57],"as":[58,88],"an":[59,89],"effective":[60],"strategy":[61],"alleviating":[63],"colitis.":[65],"MATERIALS":[66],"AND":[67],"METHODS:":[68],"We":[69],"propose":[70],"novel":[72],"rosiglitazone-phosphatidylserine":[73],"composite":[74],"nanoparticle":[75,83,112],"(PLN-PSR).":[76],"Through":[77],"precipitation-self-assembly":[78],"synthesis,":[79],"polymer-lipid":[81],"hybrid":[82],"externalizes":[84],"phosphatidylserine,":[85],"which":[86,117],"serves":[87],"\\"Eat":[90],"Me\\"":[91],"signal.":[92],"This":[93],"signal":[94],"captured":[96],"by":[97],"macrophage":[98,152,161,165],"receptors,":[99],"triggering":[100],"phagocytosis":[101,162],"prompting":[103],"scavenge":[106],"inflamed":[107,141],"areas.":[109],"Simultaneously,":[110],"releases":[113],"encapsulated":[115],"rosiglitazone,":[116],"alleviates":[118],"in":[121,140],"colonic":[122],"via":[124,160],"proliferator-activated":[126],"receptor":[127],"gamma":[128],"(PPAR-γ)":[129],"pathway.":[130],"RESULTS:":[131],"PLN-PSR":[132,155],"showed":[133],"good":[134],"stability":[135],"biocompatibility,":[137],"targeted":[138,157],"colon,":[142],"alleviated":[143],"dextran":[144],"sulfate":[145],"sodium":[146],"(DSS)-induced":[147],"colitis,":[148],"promoted":[150],"M1-to-M2":[151],"polarization.":[153],"CONCLUSIONS:":[154],"enables":[156],"delivery":[159],"modulates":[164],"function,":[166],"representing":[167],"promising":[169],"UC":[170],"therapy.":[171]}
Authors
- Ruihan Zou
- Zhining Fan (ORCID: https://orcid.org/0000-0002-4100-912X)
- Xiaohan Jiang (ORCID: https://orcid.org/0009-0000-8871-3088)
- Min Wang (ORCID: https://orcid.org/0000-0002-9115-3525)
- Hao Wu (ORCID: https://orcid.org/0009-0002-4455-3371)
Institutions
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Nanomedicine
- Published
- 2026-09-11
- DOI
- https://doi.org/10.1080/17435889.2026.2729127
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00